Michael Moye, President and General Manager of Idorsia US, commented: “The fact that the FDA has expedited the approval of the updated TRYVIO label to remove the REMS requirements is, I believe, a ...

General practitioners are now "prescribing" parkrun for their patients as part of a social prescribing initiative to promote ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal Health ...

CVS Health® (NYSE: CVS) today announced two leadership updates. Brian Newman has been named executive vice president ...

Leading pharmacy benefit managers are shifting away from lucractive rebates on biologic drugs and toward lower-cost ...

The purpose of black box warnings is to draw immediate attention to the most serious potential adverse effects of a drug, ...

President Donald Trump signed an order promising to “Make America Healthy Again” by giving patients accurate healthcare ...

The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...

Just as it took time for other sexual orientations to gain mainstream recognition, aces are fighting for a world where they ...

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...

Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, for the treatment of warm autoimmune hemolytic anemia (wAIHA) and ...

Some patients say that with research and persistence, they’ve been able to make price transparency work for them.